64Cu-GQ9001

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug Name64Cu-GQ9001

Drug Alias Name⁶⁴Cu-labeled anti-PSMA nanobody-based RDC (GeneQuantum Healthcare)64Cu GQ-9001GR-9001

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody) +[4]

Mechanisms of ActionAnti-PSMA

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A